Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:administered_by |
gptkb:Skin
gptkb:healthcare_professionals flu season |
| gptkbp:approves |
gptkb:2003
gptkb:FDA |
| gptkbp:available_in |
single-dose prefilled sprayer
|
| gptkbp:average_temperature |
-15 to -25 degrees Celsius
|
| gptkbp:can_cause |
muscle pain
cough runny nose fever in children mild respiratory symptoms |
| gptkbp:clinical_trial |
conducted for safety and efficacy
|
| gptkbp:contains |
live attenuated viruses
|
| gptkbp:contraindication |
pregnant women
individuals with severe allergies to components |
| gptkbp:dose |
0.2 m L
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flumist
|
| gptkbp:is |
suitable for everyone
a substitute for the flu shot |
| gptkbp:is_available_in |
gptkb:various_countries
|
| gptkbp:is_considered |
safe for most people
a key tool in flu prevention an effective flu vaccine |
| gptkbp:is_evaluated_by |
gptkb:guidelines
public health policies safety studies immunogenicity studies vaccine effectiveness studies |
| gptkbp:is_part_of |
public health initiatives
immunization schedules preventive healthcare measures annual flu vaccination campaign |
| gptkbp:is_recommended_by |
gptkb:CDC
|
| gptkbp:is_recommended_for |
healthy adults
healthy children healthy individuals aged 2 to 49 |
| gptkbp:is_used_in |
pediatric populations
adult populations |
| gptkbp:manufacturer |
gptkb:Med_Immune
|
| gptkbp:requires |
annual vaccination
|
| gptkbp:service_frequency |
gptkb:annually
|
| gptkbp:side_effect |
headache
fever sore throat nasal congestion muscle aches |
| gptkbp:suitable_for |
immunocompromised individuals
children under 2 years individuals with asthma adults over 50 years individuals with chronic respiratory diseases |
| gptkbp:type |
live attenuated influenza vaccine
|
| gptkbp:used_for |
influenza prevention
|
| gptkbp:bfsParent |
gptkb:Med_Immune
|
| gptkbp:bfsLayer |
5
|